The nearly perfect synchrony of nuclear division in a plasmodium of Physarum polycephalum provides a powerful system to analyze topoisomerase II cleavage sites in the course of the cell cycle. The histone H4 locus, whose schedule of replication and transcription is precisely known, was chosen for this analysis. Drug-induced topoisomerase II sites are clustered downstream of the histone H4 gene and appear highly dependent on cell cycle stage. They were only detected in mitosis and at the very beginning of S phase, precisely at the time of replication of the histone H4 region. The sites, which were absent in G2 phase, reappeared at the next mitosis. Remarkably, DNase I hypersensitive sites occurred in nearly the same location, but their schedule was totally different: they were absent in mitosis and present in G2. This schedule follows H4 transcription, which peaks in mid-S phase and in the second part of G2 phase and is off during mitosis. These results suggest that topoisomerase II may not be involved in transcription, but plays a role in remodeling chromatin structure, both during chromosome condensation in prophase/metaphase to allow their decatenation and during chromosome decondensation after metaphase to allow replication fork passage throughout the region.
INTRODUCTION
A considerable amount of knowledge has been accumulated on DNA topoisomerases during the past two decades (1) . Some of the major roles of these enzymes in the living cell were determined by the use of inhibitors and mutants. Using the latter approach, topoisomerase II was found to be essential to perform complete unlinking of newly replicated chromosomal DNA during mitosis in yeast (2) (3) (4) and to control the level of DNA supercoiling, at least in prokaryotes (5) . However, a number of other functions of topoisomerase II in the eukaryotic cell remain unclear. For instance, their precise roles in initiation of DNA replication and in transcription are not known. These enzymes are thought to participate in control of chromatin condensation-decondensation (6, 7) and in anchorage of chromatin loops to the nuclear matrix (8, 9) , but the mechanisms involved are again not known.
Another approach to the function of topoisomerase II has been to map in vivo the sites of action of this enzyme in a region of DNA at a given time. To do this cells are treated with a variety of topoisomerase II poisons (10, 11) . This treatment results in trapping of the topoisomerase at its sites, forming complexes in which the DNA is cleaved and the two enzyme subunits are covalently bound to the DNA 5′-ends. Sites of DNA cleavage are subsequently mapped by indirect end-labeling. Using this approach, in vivo topoisomerase II sites were identified near replication origins and termini, where they are supposed to be involved in decatenation of daughter DNA molecules and possibly in initiation of DNA replication (12) (13) (14) . Topoisomerase II sites were also found in the promoter regions of highly transcribed genes, such as heat shock genes (15) , c-myc (16) and globin genes (17) , but these sites seem related to the state of condensation or accessibility of chromatin in the region, rather than to the level of transcription itself. For instance, major topoisomerase II sites appear in the c-myc locus only in tumor cell lines in which the gene is transcribed at a high rate (18) . Remarkably, these sites persist even when c-myc transcription stops after the first exon, presumably because chromatin remains in an accessible conformation (19) . In the case of the HSP70 gene, topoisomerase II sites are profoundly changed upon heat shock, in correlation with decondensation of chromatin occurring at this locus. It was suggested that topoisomerase II is required for re-establishment of condensed chromatin during heat shock recovery (15) . Finally, topoisomerase II sites were found in the vicinity of matrix-or scaffold-associated regions (MARs or SARs), suggesting a role for the enzyme in anchorage of chromatin loops (7, 9, (20) (21) (22) . For instance, prominent topoisomerase II sites were detected in GC-rich sequences present within the SARs of Drosophila histone repeats (23) . However, the main difficulty with these studies is that the experiments were performed on cell populations that are not synchronous (or poorly synchronized): it is therefore not possible to detect sites of topoisomerase II action that appear, increase and rapidly disappear as a function of time at a given locus.
To study the sites of topoisomerase II activity during the cell cycle we have chosen the highly synchronous system Physarum *To whom correspondence should be addressed. polycephalum. This lower eukaryote exists as a plasmodium, whose nuclei divide with nearly perfect synchrony (24) . There is no G1 phase, so that S phase immediately follows mitosis and its timing is easy to determine. Moreover, the schedule of replication of individual genes during S phase has been determined with unusual precision (25) . The system therefore appears ideal to study precise events occurring in the course of the cell cycle. In a previous work we showed that it was possible to analyze the in vivo topoisomerase II cleavage sites in Physarum ribosomal (r)DNA using the quinolone CP-115,953 as a specific topoisomerase II poison (26) . Two classes of sites were identified, as previously defined by Käs and Laemmli (23) : those which correlate with DNase I hypersensitive sites and most likely correspond to an open chromatin configuration found in the transcribed region; internucleosomal cleavage sites located near replication origins of the rDNA unit. Drug-induced topoisomerase II cleavage in rDNA was considerably reduced upon Physarum differentiation to a dormant stage of life, the spherule. In contrast, the level of cleavage increased during metaphase, when rDNA is not transcribed. These results suggested a role for topoisomerase II in segregation of rDNA minichromosomes (26) . However, since rDNA is extra-chromosomal, its replication is not as precisely scheduled as are chromosomal genes, so that it was not possible to correlate topoisomerase II sites with rDNA replication.
In the present study we took full advantage of the precise synchrony of Physarum to analyze topoisomerase II sites in a chromosomal context during the cell cycle. We chose the region histone H4, whose schedule of replication and transcription is accurately known (27, 28) . Our results demonstrate that topoisomerase II sites are clustered in the 3′-region of the H4 gene and are present only at certain stages of the cell cycle, restricted to mitosis and the onset of S phase. Remarkably, DNase I hypersensitive sites were detected in the same region, but their schedule was different.
MATERIALS AND METHODS

Culture of Physarum
Microplasmodia of P.polycephalum (strain M3CIV) were grown in shaken cultures at 24_C in semi-defined medium (29) . Synchronous macroplasmodia were obtained by coalescence of microplasmodia on filter paper as described (30) . Mitosis was followed in ethanol-fixed smears using phase contrast microscopy. After microplasmodia fusion the second (mitosis II) and third mitoses (mitosis III) were observed to take place X16 and 26 h after nutrient medium was added.
Physarum isolated nuclei
Nuclei were prepared by homogenization of a synchronous macroplasmodium in 200 ml buffer A (10 mM Tris-HCl, pH 8.0, 10 mM CaCl 2 , 0.1% Nonidet P40 and 0.25 M sucrose) at 4_C using a Warring Blendor. Nuclei were filtered, pelleted at 4_C for 5 min at 800 g, washed in 20 ml of the same buffer and pelleted again. For experiments at various times on the same plasmodium a Dounce homogenizer (Potter) was used instead of the Warring Blender: pieces of a synchronous macroplasmodium were harvested at various times in 15 ml buffer A and nuclei isolated after 10 strokes at 4_C. Nucleus isolation was checked under a phase contrast microscope. 
Enzymes and drugs
Restriction enzymes were purchased from New England Biolabs. Klenow fragment and DNase I were from Boehringer. mAMSA (amsidine; a gift of J.-F.Riou, Rhône-Poulenc Rorer) and VM-26 (provided by Sandoz) were stored at -20_C as a 10 mM solution in DMSO. CP-115,953 (kindly provided by Pfizer Inc.) was stored at 5 mM concentration in 10 mM Tris-HCl, pH 7.9 at -80_C.
In vitro topoisomerase II cleavage reaction
Two pBR322-derived plasmids containing sequences from the histone H4 1 locus were provided by F.X.Whilelm (31) . They are represented in Figure 1 : pΦH121 contains a 4 kb BamHI-EcoRI insert encompassing the gene encoding histone H4 1 and the downstream region; pΦH125 contains a 2.5 kb EcoRI-BamHI insert containing the region upstream of the H4 1 gene. Plasmids pΦH121 and pΦH125 were digested with PvuI and SalI (cutting in vector sequences) to give 4.9 and 3.4 kb fragments respectively containing the genomic inserts. These fragments were gel purified and subsequently labeled at their SalI site using [α-32 P]dTTP (3000 Ci/mmol; Amersham) and Klenow enzyme (see Fig. 1 ). Unique labeling at the SalI end was checked by restriction enzyme digestion of the purified labeled fragment. λ DNA restricted with AseI and labeled by the same procedure as above was used as a size standard.
Yeast topoisomerase II was purified as described (32) . About 20 ng each labeled fragment were incubated with 1-10 ng purified topoisomerase II in 50 mM Tris-HCl, pH 7.9, 100 mM KCl, 15 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM dithiothreitol and 15 µg/ml BSA for 10 min at 30_C. The reaction was stopped by addition of SDS (0.5% final) and proteinase K (250 µg/ml final). The sample was further incubated at 55_C for 30 min. Samples were electrophoresed through agarose gels in TEP buffer (36 mM Tris, 30 mM NaH 2 PO 4 , 1 mM EDTA, pH 7.8). The gels were dried and autoradiographed with Hyperfilm (Amersham).
Mapping strategy and probes
In Physarum there are two genes, H4 1 and H4 2 , encoding histone H4. The two genes were shown to be transcribed and replicated at the same time during the cell cycle and are both linked to a replication origin located in their promoter region (27) . A region of at least 6.4 kb containing the H4 gene is duplicated at different loci, since all probes derived from this region hybridize with the two gene loci (not shown). We thus chose restriction enzymes whose sites are conserved in the H4 1 and H4 2 loci to map the cleavage sites in both regions by indirect end-labeling. The mapping strategy is shown in Figure 1 .
Fragments used as probes were derived by PCR from cloned Physarum DNA. From plasmid pΦH121 we derived probe 2, a 400 bp fragment amplified with primers between BamHI and HindIII sites just upstream of the H4 1 gene. Probe 1, a 335 bp fragment starting from the SmaI site in pΦH125, was generated with primers located 1.2 kb upstream of probe 2 ( Fig. 1) . 32 P-Labeled probes were made by the random priming method as recommended by the manufacturer (Boehringer), using 75 µCi [α-32 P]dCTP (3000 Ci/mmol; Amersham).
CP-115,953-induced topoisomerase II and DNase I cleavage sites in isolated nuclei
For determination of topoisomerase II cleavage sites, isolated nuclei were resuspended in 10 ml buffer B (5 mM KH 2 PO 4 , 100 mM NaCl, 5 mM MgCl 2 , 2 mM CaCl 2 , 1 mM EGTA, 0.5 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 0.25 M sucrose, pH 6.2) and, following pelleting at 4_C at 800 g for 5 min, resuspended in buffer B plus 0.2 mM ATPγS. After 5 min on ice the nucleus suspension was divided into 0.5 ml aliquots and the topoisomerase II poison was added to the final concentration indicated in the text. After 30 min incubation at 26_C the reaction was stopped by sequential addition of 1% SDS, 25 mM EDTA and 500 µg/ml proteinase K. The reaction was further incubated for 16 h at 50_C. The lysate was extracted with phenol/chloroform, treated with 100 µg/ml RNase A for 30 min at 37_C, extracted once with phenol/chloroform, once with chloroform and finally ethanol precipitated. Genomic DNA was resuspended in TE (10 mM Tris-HCl, pH 7.5, 1 mM EDTA).
For identification of DNase I sensitive sites, isolated nuclei were washed in 5 ml DNase I buffer (15 mM Tris-HCl, pH 7.4, 60 mM KCl, 15 mM NaCl, 0.5 mM dithiothreitol, 0.05 mM CaCl 2 , 1 mM MgCl 2 , 0.25 M sucrose). After pelleting for 5 min at 800 g at 4_C nuclei were resuspended in DNase I buffer, divided into 0.5 ml aliquots and kept at 4_C. DNase I was diluted before use in 25 mM Tris-HCl, pH 7.6, 30% glycerol and added to nuclei for 5 min at 26_C. The DNase I reactions were stopped by addition of 40 µl 0.1 M EDTA and 2.5% SDS. Finally, proteinase K was added to 500 µg/ml and incubation continued for 16 h at 50_C. Genomic DNA was then purified as described above.
About 10 µg genomic DNA were cleaved with restriction enzymes overnight. Samples were then incubated with 200 µg/ml proteinase K for 30 min at 55_C, phenol/chloroform extracted and ethanol precipitated. After resuspension in TE, DNA was electrophoresed through 0.8-1% agarose gels at 1.2 V/cm overnight in TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.0). After HCl depurination the DNA was transferred to Hybond N + (Amersham) in 20× SSC solution (1× SSC = 0.15 M NaCl, 0.015 M sodium citrate) as described (33) . Prehybridization and hybridization with the appropriate probe were performed at 42_C in 50% formamide, 5× SSC, 5× Denhardt's reagent, 1% SDS, 25 mM NaH 2 PO 4 , pH 6.8, 100 µg/ml denatured salmon sperm DNA. Membranes were washed at a final stringency of 0.2× SSC, 0.1% SDS at 65_C and later exposed for 3-8 days with intensifying screens at -80_C. For removal of the probe, filters were washed twice with boiling 0.5% SDS for 30 min each time.
For quantitation and positioning of the cleavage sites, membranes were exposed to phosphor screens that were subsequently analyzed using a Molecular Dynamics 400A Phosphorimager and ImageQuant software.
CP-115,953-induced topoisomerase II cleavage analyzed by pulse field gel electrophoresis
Nucleus concentration in buffer B was adjusted to 3.2 × 10 8 nuclei/ml as described (34) . After incubation of nuclei with the quinolone CP-115,953 as described above, 1 vol 1% low melting point agarose (Seaplake, FMC) in buffer B containing the same concentration of drug was added to the nucleus suspension and the mixture was allowed to harden at room temperature. Agarose plugs were dialyzed against 1% SDS at room temperature for 2 h. EDTA (to 0.2 M) and proteinase K (to 500 µg/ml) were added and the plugs were dialyzed again at 50_C for 24 h. Plugs were then dialyzed four times against 0.2 M EDTA at 4_C for 1 h each time and were stored in this solution at 4_C. About 8 µg intact genomic DNA embedded in agarose were loaded on a 1% agarose gel and electrophoresed at 14_C in 0.5× TBE buffer (45 mM Tris, 45 mM boric acid, 1 mM EDTA, pH 8) using a CHEF MAPPER (BioRad) apparatus. Southern blots were then performed as described above.
RESULTS
Long range topoisomerase II cleavage induced in the chromosomal DNA of Physarum
To map topoisomerase II cleavage sites in the chromosomal DNA of Physarum we first checked the long range cleavage induced by incubation of nuclei with a specific topoisomerase II poison, the quinolone CP-115,953 (35) . In a previous study this agent appeared to efficiently stimulate in vivo topoisomerase II cleavage in the extra-chromosomal rDNA of Physarum (26) .
Incubation of nuclei from a G2 phase plasmodium with increasing amounts of CP-115,953 induced extensive cleavage in bulk chromosomal DNA, as judged by the smear produced in pulse field gel electrophoresis (Fig. 2) . In addition, the 60 kb fragment of rDNA episomes, visible on ethidium bromide stained gels, disappeared after drug treatment. When agarose-embedded nuclei treated with the drug were dialyzed with EDTA before SDS addition all the cleavage observed with the drug was reversed, confirming that the decreased size of chromosomal DNA observed was due to topoisomerase II cleavage (data not shown; 36).
After hybridization with histone H4 probe the pattern of hybridizing DNA fragments was similar to that observed after ethidium bromide staining (Fig. 2) . This result indicates that the histone H4 gene is located on a chromosomal region cleaved similarly to the bulk chromosomal DNA. This long range topoisomerase II cleavage was detected at all stages of the cell cycle (data not shown). Using two different size separation scales The evidence for cleavage in the region of histone H4 prompted us to more precisely map topoisomerase II sites in this locus. We first looked for drug-induced topoisomerase II cleavage sites on naked DNA within a 6.4 kb region surrounding the H4 gene (Fig. 1) . Two DNA fragments (121 and 125, see Materials and Methods) were tested by incubation with purified yeast topoisomerase II. As shown in Figure 3A , there were no detectable sites in the region upstream of the H4 gene. In contrast, several cleavage sites were revealed downstream of the H4 1 coding sequence: a group of three prominent sites (sites 1-3) and two other sites, one within the H4 coding sequence (site 6) and the other downstream of the stop codon (site 5; Fig. 3B ). The level of CP-115,953-induced cleavage was nearly the same with 10, 2 or 1 ng topoisomerase II (lanes 3-5), suggesting that the drug was able to efficiently trap the enzyme on its sites. Finally, the various sites were not equally stimulated by different topoisomerase II poisons (Fig. 3B,  lanes 5-7) . The cleavage pattern observed with the non-intercalating drug VM-26 was similar to that of CP-115,953, with sites 5 and 6 more prominent (lane 6). The pattern with the intercalating drug mAMSA was clearly different (lane 7).
Topoisomerase II cleavage sites occur in the histone H4 locus in metaphase nuclei but are not detectable in asynchronous (microplasmodia) nuclei
In order to determine whether the cleavage sites obtained in vitro could be seen in isolated nuclei and if their appearance was cell cycle dependent, we took advantage of the rigorous synchrony of Physarum plasmodia. We first compared topoisomerase II cleavage sites within the H4 locus in asynchronous microplasmodia and in metaphase plasmodia.
Sites were investigated in the 6.5 kb SmaI restriction fragment encompassing the H4 gene (Fig. 1) . We did not detect any topoisomerase II cleavage site in this region in microplasmodia (Fig. 4A, lane 2) , although the region was DNase I hypersensitive (Fig. 4A, lane 5) . In contrast to what was seen in microplasmodia, a group of topoisomerase II cleavage sites (sites 1-4) appeared downstream of the H4 gene in nuclei of a metaphase II plasmodium incubated with the drug (Fig. 4A, lane 7) . Remarkably, at the same time, DNase I hypersensitive sites were no longer detectable (Fig. 4A, lane 10) . The location of topoisomerase II sites 1-3 appears to coincide with DNase I sites 1′-3′ seen in microplasmodia, within the limit of resolution of the gel system used (see also Fig. 6 ). An additional DNase I site appeared just upstream of the H4 gene, in the promoter region, but did not correspond to a site of topoisomerase II cleavage. Also remarkable is the observation that sites 1-3 are in the same location as the VM-26-and CP-115,953-induced topoisomerase II sites mapped on naked DNA. Site 4, located closer to the H4 gene, was not detected in vitro. Faint cleavage products also occurred within the coding sequence.
To validate the results obtained with the quinolone CP-115,953 we compared these data with the cleavage patterns induced in metaphase nuclei by two other specific topoisomerase II inhibitors, mAMSA and VM-26 (Fig. 4B) . The results obtained with these inhibitors confirm the presence of topoisomerase II sites downstream of the histone H4 gene. In contrast to results obtained in vitro (Fig. 3) , all three drugs yielded a similar pattern of topoisomerase II cleavage. The one exception was site 4, which is not observed in the presence of mAMSA or VM-26.
Topoisomerase II cleavage sites in the histone H4 region are cell cycle dependent but do not correlate with the appearence of DNase I sites Because of the appearance of topoisomerase sites in metaphase II, we looked more precisely at the behavior of these sites throughout the cell cycle. In Physarum there is no G1 phase. The cell cycle is ∼10.5 h long, with a 30 min mitosis, immediately followed by a 3 h S phase and then a G2 phase that is 7 h long (30) . It is therefore easy to determine the precise schedule of cell cycle events.
For each time point a macroplasmodium was harvested and isolated nuclei were incubated with 100 µM CP-115,953 to induce endogenous topoisomerase II cleavage. Figure 5 shows the strong cell cycle dependence of CP-115,953-induced topoisomerase II cleavage: topoisomerase sites are detectable during prophase and 7 min before metaphase II (Fig. 5, lane 2) and begin to disappear The synchronous macroplasmodium in metaphase II or microplasmodia were harvested and isolated nuclei were split into two portions and incubated with either CP-115,953, to induce topoisomerase II cleavage, or with DNase I. Genomic DNA was then prepared and digested with SmaI to give a 6.5 kb fragment and hybridized with probe 1 (see Fig. 1 ). Lanes 1 and 6, controls without drug; lanes 2 and 7, nuclei incubated with 100 µM CP-115,953; lanes 3 and 8, without DNase I; lanes 4 and 9, 0.1 U/ml DNase I; lanes 5 and 10, 1 U/ml DNase I. (B) Cleavage induced by various topoisomerase II poisons in a synchronous macroplasmodium in mitosis (metaphase II). Nuclei of a synchronous macroplasmodium in metaphase II were split into aliquots and incubated with drug for 30 min at 26_C. Genomic DNA was digested with SmaI and probed. Lane 1, no drug control; lanes 2 and 3, 10 and 100 µM mAMSA respectively; lanes 4 and 5, 10 and 100 µM CP-115,953; lanes 6 and 7, 10 and 100 µM VM-26. In (A) and (B) the arrows numbered 1-4 indicate the fragments that correspond to topoisomerase II cleavage sites and arrows 1′-3′ refer to DNase I hypersensitive sites described in the text. Sites 1 and 1′ correspond to a 3.6 kb fragment; sites 2 and 2′ to a 3.44 kb fragment; sites 3 and 3′ to a 3.24 kb fragment; site 4 to a 2.94 kb fragment. These sites are located at 1.9 (sites 1 and 1′), 1.7 (sites 2 and 2′), 1.5 (sites 3 and 3′) and 1.24 kb (site 4) from the initiation codon of the H4 gene. Fig. 1 ). The numbers above peaks indicate the DNase I hypersensitive sites (1′-3′) or the CP-115,953-induced topoisomerase II cleavage sites (1-4) . The various DNA fragments are: sites 1 and 1′ correspond to a 2.5 kb fragment; sites 2 and 2′ to a 2.3 kb fragment; sites 3 and 3′ to a 2.1 kb fragment; site 4 to a 1.8 kb fragment. These sites are located at 1.9 (sites 1 and 1′), 1.7 (sites 2 and 2′), 1.5 (sites 3 and 3′) and 1.24 (site 4) kb from the beginning of the gene. The asterisk indicates an extra topoisomerase II site during metaphase.
at ∼30 min after metaphase, during the first part of S phase (lane 7). During G2 phase the region is not cleaved by topoisomerase II (at +180 and 540 min after metaphase II; lanes 12 and 17). In metaphase III topoisomerase sites again appear (lane 22), with a pattern identical to that of metaphase II.
Also, as is evident from Figures 4A and 5 , there is a lack of correlation between the times of appearance of DNase I and topoisomerase II site cleavage: during the two consecutive metaphases II and III, DNase I hypersensitive sites disappear (Figs 4A, lane 10, and Fig. 5, lane 25) at the time when these (or very close) sites are cleaved by topoisomerase II. DNase I hypersensitivity reappears 30 min after metaphase, during S phase and is prominent at the end of S phase (Fig. 5, lanes 10 and  15) . Finally, consistent with the results obtained on microplasmodia, DNase I hypersensitivity persists during G2 phase (at +180 and Phosphorimager quantification of cleavage intensity (Fig. 6 ) confirmed the coincidence of DNase I (1′-3′) and topoisomerase II (1-3) sites and revealed an additional cleavage site that is reproducibly found during metaphases II and III (located between sites 2 and 3). This site is not present during prophase and disappears very quickly at the beginning of S phase (Fig. 6) .
Phosphorimager quantification of the overall CP-115,953-induced topoisomerase II cleavage at each time point of the cell cycle in the 6.5 kb SmaI fragment is shown in Figure 7 . Cleavage essentially occurs around each mitosis. Maximum cleavage level around mitosis II occurred at ∼5-10 min after metaphase, which corresponds to the very beginning of S phase. In this case cleaved DNA represents ∼10% of total DNA. These experiments were done using independent plasmodia. Since there is a variation of ± 2% in the intensity of cleavage in samples from different plasmodia, one cannot determine the exact time when cleavage is maximal during the cell cycle. To more precisely measure this time we analyzed topoisomerase II cleavage during mitosis and the beginning of S phase in a single plasmodium. Parts of a single plasmodium were harvested every 5 min to prepare nuclei. Two series of experiments were done.
The first experiment was on a plasmodium in prophase, from 20 to 5 min before metaphase. We verified that S phase had not begun in this plasmodium, since no replication intermediates could be detected (not shown). As shown in Figure 7 , inset, topoisomerase II cleavage levels increased as nuclei progressed into mitosis.
In the second experiment nuclei were isolated from a macroplasmodium from 1 min before to 12 min after metaphase (Fig. 7,  inset) . Maximum cleavage occurred 9 min after metaphase, at a time that corresponds to the onset of S phase and the beginning of H4 gene replication (27; Gérard Pierron, personal communication).
DISCUSSION
The experiments described in this paper provide the first demonstration that topoisomerase II sites in a chromosomal locus are strongly cell cycle dependent. This was made possible by the nearly perfect synchrony of nuclear division in a Physarum plasmodium. Short range cleavage sites were detected within a 6.6 kb region in conventional agarose gels. These sites are clustered downstream of the H4 gene, four of them in a 500 bp segment, and occur exclusively in the 30 min period that contains mitosis and the very beginning of S phase. The shortness of this period relative to the 10.5 h length of the complete cell cycle explains why these topoisomerase II sites are not detected in asynchronous microplasmodia: indeed, in an exponentially growing culture of microplasmodia there are ∼67% nuclei in G2 phase, 28% in S phase and 5% in mitosis. Cleavage sites, which are absent in G2, reappear precisely at the next metaphase (metaphase III). This illustrates the high degree of synchrony of the system. It is worth distinguishing this short range cleavage seen in the vicinity of H4 from the long range cleavage detected by pulse field electrophoresis in a region of 20-200 kb encompassing the H4 probe. This cleavage may represent clusters of sites corresponding to anchorage points for chromatin loops, as suggested by Razin (9) . Contrary to short range sites, they are detected during all the cell cycle stages and may thus be cell cycle independent.
One of the main questions addressed in studies of topoisomerase II sites is whether or not they are related to gene expression (17, 18) . In Physarum plasmodia, histone H4 genes are transcribed with a precise schedule (28, 37) . Two peaks of transcription have been described: one is coupled to S phase, with a peak at the middle of S phase; the other begins after mid-G2, peaks at about 75 min before mitosis and ends before it. Our experiments with DNase I are consistent with this scheme: hypersensitive sites in the H4 region appear during S phase and persist in G2 phase, but disappear at each mitosis. Remarkably, both topoisomerase II and DNase I sites seem to occur at the same locations downstream of the H4 gene (given the precision of ∼100 bp of the agarose gel analysis), but their timing is completely different. This strongly suggests that topoisomerase II cleavage is not related to H4 transcription. Instead, we suggest that topoisomerase II is required in metaphase and during replication of the H4 gene. The appearance of topoisomerase II sites at prophase, increasing towards metaphase, coordinated with the disappearance of DNase I sensitivity, suggests a role for topoisomerase II in remodeling of chromatin structure during chromosome condensation and allowing their correct decatenation. The same conclusion of a role for topoisomerase II in decatenation was proposed in the case of rDNA minichromosomes, for which we found enhanced topoisomerase II cleavage although transcription was off (26) . It is noteworthy that early experiments using alkaline elution suggested that overall DNA cleavage induced by topoisomerase II poisons in mammalian cells was considerably increased during mitosis (38, 39) . In the same way, since the gene is replicated during the first 10 min of S phase, it is tempting to speculate that occurrence of topoisomerase II sites at this time correlates with rapid chromosome decondensation after metaphase, to allow replication fork passage throughout this region. Supporting this view is the recent finding that topoisomerase II is part of a chromatin remodeling factor (40) . Evidence that topoisomerase II cleavage in H4 is not related to transcription is also substantiated by the absence of topoisomerase II sites in the promoter region of the gene, contrary to several highly transcribed genes.
Also remarkable is the finding that the topoisomerase II sites detected downstream of the H4 gene during the cell cycle seem identical to the sites found on naked DNA with purified heterologous topoisomerase II in the presence of drugs. No additional major site occurs in vitro that was not also detected in nuclei. This finding suggests that sequences specific for topoisomerase II were maintained during evolution, since these sequences were effectively used by the enzyme in vivo. Thus the idea that in vivo topoisomerase II sites are selected from a vast repertoire of in vitro specific sequences on the basis of their accessibility within chromatin (41, 42) has to be completed by the possibility that the sequences that were not accessible were presumably not conserved in evolution, explaining the high similarity between in vitro and in vivo results.
From these different results comes the notion of functional sites for topoisomerase II. In contrast to DNase I sites, these sites do not simply reflect accessibility of the chromatin, but functioning of the enzyme on its sites to fulfill specific roles at precise times of the cell cycle.
